HDA Media And Political Bulletin – 10 June 2016

Media Summary

APPG CHAIR ASKS BURT FOR MEETING OVER DRUGS SHORTAGES

9 June 2016, Pharmacy Biz, Neil Trainis

 

Pharmacy Biz reports that Sir Kevin Barron, chair of the All-Party Pharmacy Group, the APPG, has written to social care minister Alistair Burt requesting a meeting to discuss the ongoing issue of medicine shortages in the UK. Barron drew attention to a survey carried out by the APPG, which reveals that the problem of shortages has not been resolved yet. He added that: “the best action would be for the DH, NHS England and MHRA to work together to establish a system that accurately monitors medicines entering the supply chain, detects the shortage risks and helps supply chain participants alleviate the impact of shortages where they do occur”.

 

The full letter is available to read here.

Parliamentary Coverage

 

There is no Parliamentary coverage today.

 

Full Coverage

APPG CHAIR ASKS BURT FOR MEETING OVER DRUGS SHORTAGES

9 June 2016, Pharmacy Biz, Neil Trainis

 

Sir Kevin Barron, the chair of the All-Party Pharmacy Group, has written to the social care minister Alistair Burt asking to meet to discuss ways of solving the medicines shortage which continues to blight community pharmacy and endanger patients.

 

In his letter Barron (pictured) drew Burt’s attention to a survey carried out by the APPG revealing that the problem of shortages has far from been resolved despite the insistence of some in the pharmaceutical industry that the issue has been blown out of proportion.

 

Thomas Broeer, the vice-chair of the British Generic Manufacturers Association, told Pharmacy Business in 2014 when he chaired the organisation that generic drug shortages did not exist. During last year’s Avicenna conference in northern Cyprus, Sigma director Rajiv Shah insisted generic drug shortages cost independent pharmacists £10 million a year.

 

The APPG survey reinforced concerns that shortages remain a big problem, with 48% of community pharmacists surveyed saying shortages may have or did require patients receive “moderate medical treatment” when pharmacies were unable to dispense their prescribed medicine. Some 3% said this may have or did lead to a patient being hospitalised.

 

“Earlier this year, the All-Party Pharmacy Group and North of England Commissioning Support (NECS) conducted a survey to assess the impact medicine shortages have on NHS services and on patients,” Barron wrote.

 

“Those who participated in the survey were pharmacists in hospitals and in the community, and GPs and CCGs in the North East of England.

 

“Overall, it is clear from the survey that medicines shortages continue to occur. They cause inconvenience, stress and, on occasion, physical harm to patients. They cause disruption for health professionals and support staff, meaning that valuable NHS time is wasted on a regular and continuing basis.”

 

During the APPG survey 56% of community pharmacists said a medicine out of stock on a prescription presented at their pharmacy was “almost certain to occur” once a day and 36% said it was “likely to occur” once a week.

 

Forty-eight percent of community pharmacists also said they spent between 21 and 50 hours each month dealing with medicines shortages while 16% said they were spending 51 to 75 hours and 5% were spending over 100 hours.

 

“The survey asked for respondents’ views on the most helpful actions or solutions. Many felt that the best action would be for the DH, NHS England and MHRA to work together to establish a system that accurately monitors medicines entering the supply chain, detects the shortage risks and helps supply chain participants alleviate the impact of shortages where they do occur,” Barron wrote.

 

“I would welcome the opportunity for APPG officers to meet with you and representatives of the MHRA to discuss these findings in more detail and to consider actions that would improve the situation for patients and healthcare professionals.

 

“I hope we are agreed that GPs and pharmacists should spend their time diagnosing, treating and supporting patients rather than dealing with medicine shortages.”

 APPG ‘surprised’ by further decriminalisation delays

C&D, Annabelle Collins, 9 December 2015

The All Party Pharmacy Group (APPG) has expressed its disappointment that the decriminalisation of dispensing errors would not be considered by the House of Commons before Christmas, as it was originally announced. Sir Kevin Barron, chair of the APPG stated that the group welcomed the Department of Health consultation on this pressing issue.

 

NCSO/price concessions December 2015

PSNC, 9 December 2015

The Department of Health granted the following price concessions for December 2015:

The price concession only applies to the month that it is granted.

No additional endorsements are required for price concessions.

 

Drug Pack size Price concession
Celiprolol 200mg tablets 28 £19.83
Celiprolol 400mg tablets 28 £39.65
Cimetidine 400mg tablets 60 £8.00
Clindamycin 150mg capsules 24 £13.00
Diclofenac Sodium 50mg gastro-resistant tablets 28 £2.60
Lamotrigine 5mg dispersible tablets sugar free 28 £8.50
Lercandipine 20mg tablets 28 £9.85
Lithium 250mg tablets 100 £48.18
Mefenamic acid 500mg tablets 28 £12.15
Procyclidine 5mg tablets 28 £14.00

PSNC is still in discussion with the Department of Health on a number of generic medicines in short supply.

Please note that PSNC cannot provide details of generic products that are suspected of being affected by generic supply problems unless and until the Department of Health grants a concession. PSNC is in discussion with the Department of Health on a number of generic medicines in short supply.

 

 

Parliamentary Coverage

 

There is no Parliamentary coverage today.

 

Full Coverage

 

There is no additional coverage today.

From Factory to Pharmacy

As part of our mission to build awareness, understanding and appreciation of the vital importance of the healthcare distribution sector, we developed an infographic explaining the availability of medicines. It identifies the factors that can impact drug supply, as well as the measures that HDA members undertake day in, day out to help mitigate the risks of patients not receiving their medicines.

See the Infographic

Apply to become a Member

Membership of the HDA guarantees your organisation:

  • Access to leading policy and industry forums of debate and discussion
  • Invitations to a range of networking industry events organised through the year, including an Annual Conference and a Business Day
  • Representation on HDA working parties, including the Members’ Liaison Group
  • A daily Political and Media Bulletin and HDA Newsletters
  • Access to HDA policy documents and all sections of the HDA website
  • Branding and marketing opportunities
Apply Now

Already a Member?